1. Home
  2. FLUX vs LNAI Comparison

FLUX vs LNAI Comparison

Compare FLUX & LNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flux Power Holdings Inc.

FLUX

Flux Power Holdings Inc.

BUY

Current Price

$0.41

Market Cap

11.9M

Sector

Miscellaneous

ML Signal

BUY

Logo Lunai Bioworks Inc.

LNAI

Lunai Bioworks Inc.

HOLD

Current Price

$0.49

Market Cap

12.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLUX
LNAI
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.9M
12.4M
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
FLUX
LNAI
Price
$0.41
$0.49
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $4.53
N/A
AVG Volume (30 Days)
★ 503.9K
90.8K
Earning Date
11-12-2026
10-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 5.00
1.85
EPS
★ N/A
N/A
Revenue
★ $9,317,000.00
$51,992.00
Revenue This Year
N/A
N/A
Revenue Next Year
$85.96
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 126.25
N/A
52 Week Low
$0.40
$0.22
52 Week High
$7.55
$5.02

Technical Indicators

Market Signals
Indicator
FLUX
LNAI
Relative Strength Index (RSI) 36.77 15.16
Support Level $0.40 $0.45
Resistance Level $0.55 $1.65
Average True Range (ATR) 0.05 0.22
MACD -0.00 -0.06
Stochastic Oscillator 9.43 0.80

Price Performance

Historical Comparison
FLUX
LNAI

About FLUX Flux Power Holdings Inc.

Flux Power Holdings Inc. designs, develops, manufactures, and sells a portfolio of lithium-ion energy storage solutions for the electrification of a range of industrial and commercial sectors, which include material handling, airport ground support equipment (GSE), and stationary energy storage. It offers a high-power battery cell management system(BMS). The BMS serves as the brain of the energy storage solution, managing cell balancing, charging, discharging, monitoring, and communication between the pack and the forklift. The company's product portfolio includes Battery Technology and Energy Management solutions.

About LNAI Lunai Bioworks Inc.

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Share on Social Networks: